Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 617

Results For "ED"

7945 News Found

Carestream installs DRX Compass at Gati Diagnostic Centre
Medical Device | April 12, 2022

Carestream installs DRX Compass at Gati Diagnostic Centre

The DRX-Compass helps navigate and accelerate towards superb performance with a solution that grows with its customers


Pharmapack Europe 2022 to open on May 18-19 in Paris
Packaging | April 12, 2022

Pharmapack Europe 2022 to open on May 18-19 in Paris

Pharmapack trends are a key barometer of global device and packing opportunities in 2022


New very-high-sensitivity rapid antigen test kits hit Australian market
News | April 11, 2022

New very-high-sensitivity rapid antigen test kits hit Australian market

New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia


Telix Pharmaceuticals announces licence agreement with Lilly for olaratumab
Biotech | April 11, 2022

Telix Pharmaceuticals announces licence agreement with Lilly for olaratumab

Lilly may be eligible for up to US $ 225m in payments based upon the achievement of pre-specified development, regulatory and commercial milestones


Honeywell teams with AstraZeneca to develop net-gen inhalers to combat global warming
Sustainability | April 11, 2022

Honeywell teams with AstraZeneca to develop net-gen inhalers to combat global warming

Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products


Intuitive launches My Intuitive App
Digitisation | April 11, 2022

Intuitive launches My Intuitive App

The app serves as a single, integrated, personalized customer platform for da Vinci surgeons


Global pharma back Turn Biotechnologies to advance its cell rejuvenation program
Startup | April 11, 2022

Global pharma back Turn Biotechnologies to advance its cell rejuvenation program

Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas


Lonza signs manufacturing deal with Asher Biotherapeutics
Biotech | April 11, 2022

Lonza signs manufacturing deal with Asher Biotherapeutics

Under the manufacturing agreement, Lonza will provide drug substance for Asher Bio's cis-targeted IL-2 fusion protein


Amyris commissions industry-leading fermentation plant
Biotech | April 11, 2022

Amyris commissions industry-leading fermentation plant

The site consists of five fermentation "mini-factories" capable of concurrently producing our more than 13 currently scaled and future bio-fermented products


Glenmark Specialty receives DCGI approval for Phase 1 clinical trial of its novel molecule
Biotech | April 11, 2022

Glenmark Specialty receives DCGI approval for Phase 1 clinical trial of its novel molecule

GRC 54276 has shown tumour cell killing ability in preclinical studies as a single agent and as well in combination with checkpoint inhibitors, making it a high-priority target in immuno-oncology